Insider Trading
LUCY Stock | USD 3.04 0.11 3.49% |
Slightly above 61% of Innovative Eyewear's investor base is looking to short. The analysis of overall sentiment of trading Innovative Eyewear stock suggests that many investors are alarmed at this time. Innovative Eyewear's investing sentiment can be driven by a variety of factors including economic data, Innovative Eyewear's earnings reports, geopolitical events, and overall market trends.
Innovative |
Filed transaction by Innovative Eyewear Officer: Co-chief Financial Officer. Insider Public Trading
Read at forbes.com
![]() |
Innovative Eyewear Fundamental Analysis
We analyze Innovative Eyewear's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovative Eyewear using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovative Eyewear based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Innovative Eyewear is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Innovative Eyewear Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Innovative Eyewear stock to make a market-neutral strategy. Peer analysis of Innovative Eyewear could also be used in its relative valuation, which is a method of valuing Innovative Eyewear by comparing valuation metrics with similar companies.
Peers
Innovative Eyewear Related Equities
POAI | Predictive Oncology | 50.89 | ||||
MHUA | Meihua International | 2.94 | ||||
ISRG | Intuitive Surgical | 2.21 | ||||
BNGO | Bionano Genomics | 1.54 | ||||
STXS | Stereotaxis | 1.54 | ||||
MBOT | Microbot Medical | 0.63 | ||||
PDEX | Pro Dex | 0.76 | ||||
NXGL | Nexgel | 1.94 | ||||
ZJYL | JIN MEDICAL | 2.78 | ||||
STSS | Sharps Technology | 5.88 | ||||
GCTK | GlucoTrack | 7.41 |
Additional Tools for Innovative Stock Analysis
When running Innovative Eyewear's price analysis, check to measure Innovative Eyewear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Eyewear is operating at the current time. Most of Innovative Eyewear's value examination focuses on studying past and present price action to predict the probability of Innovative Eyewear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovative Eyewear's price. Additionally, you may evaluate how the addition of Innovative Eyewear to your portfolios can decrease your overall portfolio volatility.